Some major countries like India investing in biopharmaceutical industry have designed new business models of circular economics called the“Uber for HealthCare”for instance by Basu et al.,for medical equipment in Ind...Some major countries like India investing in biopharmaceutical industry have designed new business models of circular economics called the“Uber for HealthCare”for instance by Basu et al.,for medical equipment in India(Euro,Healthcare Stream,&Dublin 2018).This raises major challenges for global supply of medicine and Value Chains in life science.This contribution will provide a review of recent experiences and an analysis of how it impacts current global value chains.Current economic model development strengthening the demand side of the system and applications of choice modeling to capture heterogeneity of demand at individual level face with new circular strategies implemented by health care organizations and economic suppliers.The all-value system is challenged by such models including the critical decision points at prognostic,diagnostic,and treatment stages;platforms such as the Her2adaptive technology platform with cost sensitivity indexes proposed by Huttin and Liebman(Technology&HealthCare,2011)face also potential adaptation to integrate new priorities:for instance,in circular economy with integration of circular touch points.Research results like Van Boerdonk et al.(2021),demonstrate that reaching cleaner production with higher environmental values may become“paradoxical with lower or unimportant customer value”.Government and payers may need to create new policies for waste management and for sustaining reasonable and fair value for money in the health system.Moreover,the economics of sharing economy may need to find appropriate forms of centralization or decentralization in the organizations of health systems and decision-making processes.Circular models in health care in sharing economy may benefit single pathway models,often too expensive for affordable welfare contracts.This paper will continue the previous research agenda and papers on global value chains with the use of TiVa OECD database(joined in the WB-WTO project)and a quality paper on the biotech development chain and Covid-19(Huttin,2019;2021).展开更多
文摘Some major countries like India investing in biopharmaceutical industry have designed new business models of circular economics called the“Uber for HealthCare”for instance by Basu et al.,for medical equipment in India(Euro,Healthcare Stream,&Dublin 2018).This raises major challenges for global supply of medicine and Value Chains in life science.This contribution will provide a review of recent experiences and an analysis of how it impacts current global value chains.Current economic model development strengthening the demand side of the system and applications of choice modeling to capture heterogeneity of demand at individual level face with new circular strategies implemented by health care organizations and economic suppliers.The all-value system is challenged by such models including the critical decision points at prognostic,diagnostic,and treatment stages;platforms such as the Her2adaptive technology platform with cost sensitivity indexes proposed by Huttin and Liebman(Technology&HealthCare,2011)face also potential adaptation to integrate new priorities:for instance,in circular economy with integration of circular touch points.Research results like Van Boerdonk et al.(2021),demonstrate that reaching cleaner production with higher environmental values may become“paradoxical with lower or unimportant customer value”.Government and payers may need to create new policies for waste management and for sustaining reasonable and fair value for money in the health system.Moreover,the economics of sharing economy may need to find appropriate forms of centralization or decentralization in the organizations of health systems and decision-making processes.Circular models in health care in sharing economy may benefit single pathway models,often too expensive for affordable welfare contracts.This paper will continue the previous research agenda and papers on global value chains with the use of TiVa OECD database(joined in the WB-WTO project)and a quality paper on the biotech development chain and Covid-19(Huttin,2019;2021).
基金国家自然科学基金项目“基于行为洞察及田野实验开发医院WPV应对策略的方法研究”(72174049)美国中华医学基金会项目“Assessing the state of vaccine confidence and vaccine communication training for community health professionals in Northern China”(19-309)黑龙江省教育科学“十四五”规划2023年度重点课题“基于UE原理的多维视角下线上教学效果评估体系构建研究”(GJB1423202)。
